Cargando…
Rates of and Factors Associated With Primary and Booster COVID-19 Vaccine Receipt by US Veterans, December 2020 to June 2022
IMPORTANCE: COVID-19 vaccination rates remain suboptimal in the US. Identifying factors associated with vaccination can highlight existing gaps and guide targeted interventions to improve vaccination access and uptake. OBJECTIVE: To describe incidence and patient characteristics associated with prim...
Autores principales: | Bajema, Kristina L., Rowneki, Mazhgan, Berry, Kristin, Bohnert, Amy, Bowling, C. Barrett, Boyko, Edward J., Iwashyna, Theodore J., Maciejewski, Matthew L., O’Hare, Ann M., Osborne, Thomas F., Viglianti, Elizabeth M., Hynes, Denise M., Ioannou, George N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896301/ https://www.ncbi.nlm.nih.gov/pubmed/36729454 http://dx.doi.org/10.1001/jamanetworkopen.2022.54387 |
Ejemplares similares
-
Early Adoption of Anti–SARS-CoV-2 Pharmacotherapies Among US Veterans With Mild to Moderate COVID-19, January and February 2022
por: Bajema, Kristina L., et al.
Publicado: (2022) -
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomes
por: Bajema, Kristina L., et al.
Publicado: (2022) -
Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System
por: Ioannou, George N., et al.
Publicado: (2022) -
Late Mortality After COVID-19 Infection Among US Veterans vs Risk-Matched Comparators: A 2-Year Cohort Analysis
por: Iwashyna, Theodore J., et al.
Publicado: (2023) -
Anti–SARS-CoV-2 Pharmacotherapies Among Nonhospitalized US Veterans, January 2022 to January 2023
por: Yan, Lei, et al.
Publicado: (2023)